As of January 2025, Pharma Mar has a market cap of $1.46B. This makes Pharma Mar the world's 6170th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $637.68M | -15.04% |
2023 | $750.60M | -36.11% |
2022 | $1.17B | 12.77% |
2021 | $1.04B | -19.69% |
2020 | $1.30B | 65.73% |
2019 | $782.76M | 227.52% |
2018 | $238.99M | -56.05% |
2017 | $543.77M | -8.49% |
2016 | $594.20M | 7.97% |
2015 | $550.35M | -5.99% |
2014 | $585.43M | 15.58% |
2013 | $506.49M | 90.12% |
2012 | $266.40M | -29.36% |
2011 | $377.13M | -37.79% |
2010 | $606.26M | -28.18% |
2009 | $844.16M | 14.93% |
2008 | $734.53M | -45.17% |
2007 | $1.34B | 9.50% |
2006 | $1.22B | -5.10% |
2005 | $1.29B | 14.17% |
2004 | $1.13B | -8.04% |
2003 | $1.23B | 3.32% |
2002 | $1.19B | -37.99% |
2001 | $1.92B | -29.80% |
2000 | $2.73B | - |